Desisobutyryl ciclesonide
CAS: 161115-59-9
Ref. 3D-FD21205
| 1mg | Ausgelaufen | ||
| 2mg | Ausgelaufen | ||
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen |
Produktinformation
Name:
Desisobutyryl ciclesonide
Synonyme:
- (11b,16a)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dioneCIC-APCiclesonide active principle
- CIC-AP
- Pregna-1,4-diene-3,20-dione, 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxy-, [11β,16α(R)]-
- Ciclesonide active principle
- Pregna-1,4-diene-3,20-dione, 16,17-[[(R)-cyclohexylmethylene]bis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- (11β,16α)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
Beschreibung:
Desisobutyryl ciclesonide is a prodrug of ciclesonide, which is a potent and specific beta-adrenergic agonist. It has been shown to have a pharmacokinetic profile that is similar to the parent drug, with an elimination half-life of approximately six hours. Desisobutyryl ciclesonide is not metabolized by cytochrome P450 enzymes and has low oral bioavailability. The drug does not produce any significant adverse effects in animal studies when administered orally or intravenously.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
470.6 g/mol
Formel:
C28H38O6
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
